Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
Status:
Withdrawn
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the use of Flurpiridaz F18 injection in patients with CAD to
determine if the study drug in PET imaging is better than SPECT imaging currently used for
this purpose.